BioLineRx Enters Clinic with Novel Treatment for Celiac Disease
And so it begins. The first patient has been enrolled in the BioLineRx Phase 1/2 study of their agent BL-7010. BL-1070 is an agent which reduces the immune response to gluten in those with Celiac Disease by preventing the absorption of gliadin (the protein in gluten that the immune system in those with CD reacts to). It will be interesting to see the results of this study later in 2014!

Can You Trust Gluten Free Restaurant Items?
This article is a stern reminder that not all that is gluten free is gluten free, especially when it comes to restaurant dining. Several examples of wrong gluten free doings from restaurants are shared, in addition to some general tips to help prevent cross contamination.

The Boy Who Wouldn’t Grow: Liberty Sophomore Blake Walkers Battle with Celiac Disease
This personal story of one boy’s struggle before CD diagnosis shows the true nature of the disease, and the maturity and determination it takes to work towards health through a gluten free diet. A great read!